16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Molecular profiling of a simple rat model of open tibial fractures with hematoma and periosteum disruption

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Bone fractures are a worldwide public health concern. Therefore, improving understanding of the bone healing process at a molecular level, which could lead to the discovery of potential therapeutic targets, is important. In the present study, a model of open tibial fractures with hematoma disruption, periosteal rupture and internal fixation in 6-month-old male Wistar rats was established, in order to identify expression patterns of key genes and their protein products throughout the bone healing process. A tibial shaft fracture was produced using the three-point bending technique, the hematoma was drained through a 4-mm incision on the medial aspect of the tibia and the fracture stabilized by inserting a needle into the medullary canal. Radiographs confirmed that the induced fractures were diaphyseal and this model was highly reproducible (kappa inter-rater reliability, 0.82). Rats were sacrificed 5, 14, 21, 28 and 35 days post-fracture to obtain samples for histological, immunohistochemical and molecular analysis. Expression of interleukin-1β ( Il-1β), transforming growth factor-β2 ( Tgf2), bone morphogenetic protein-6 ( Bmp-6), bone morphogenetic protein-7 ( Bmp-7) and bone γ-carboxyglutamic acid-containing protein ( Bglap) genes was determined by reverse transcription quantitative polymerase chain reaction and protein expression was evaluated by immunohistochemistry, while histological examination allowed characterization of the bone repair process. Il-1β showed a biphasic expression, peaking 5 and 28 days post-fracture. Expression of Tgf2, Bmp-6 and Bmp-7 was restricted to the period 21 days post-fracture. Bglap expression increased gradually, peaking 21 days post-fracture, although it was expressed in all evaluated stages. Protein expression corresponded with the increased expression of their corresponding genes. In conclusion, a clear and well-defined expression pattern of the evaluated genes and proteins was observed, where their maximal expression correlated with their known participation in each stage of the bone healing process.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: not found
          • Article: not found

          Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis.

            Fracture healing and distraction osteogenesis have important applications in orthopedic, maxillofacial, and periodontal treatment. In this review, the cellular and molecular mechanisms that regulate fracture repair are contrasted with bone regeneration that occurs during distraction osteogenesis. While both processes have many common features, unique differences are observed in the temporal appearance and expression of specific molecular factors that regulate each. The relative importance of inflammatory cytokines in normal and diabetic healing, the transforming growth factor beta superfamily of bone morphogenetic mediators, and the process of angiogenesis are discussed as they relate to bone repair. A complete summary of biological activities and functions of various bioactive factors may be found at COPE (Cytokines & Cells Online Pathfinder Encyclopedia), http://www.copewithcytokines.de/cope.cgi.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing.

              Fracture healing is a unique postnatal repair process in which the events of endochondral and intramembranous bone formation follow a definable temporal sequence. The temporal patterns of messenger RNA (mRNA) expression for members of the transforming growth factor beta (TGF-beta) superfamily were examined over a 28-day period of fracture healing in mouse tibias. Bone morphogenetic protein 2 (BMP-2) and growth and differentiation factor 8 (GDF8) showed maximal expression on day 1 after fracture, suggesting their roles as early response genes in the cascade of healing events. Restricted expression of GDF8 to day 1, in light of its known actions as a negative regulator of skeletal muscle growth, suggests that it may similarly regulate cell differentiation early in the fracture healing process. GDF5, TGF-beta2, and TGF-beta3 showed maximal expression on day 7, when type II collagen expression peaked during cartilage formation. In contrast, BMP-3, BMP-4, BMP-7, and BMP-8 showed a restricted period of expression from day 14 through day 21, when the resorption of calcified cartilage and osteoblastic recruitment were most active. TGF-beta1, BMP-5 and BMP-6, and GDF10 were constitutively expressed from day 3 to day 21. However, during the same time period, GDF3, GDF6, and GDF9 could not be detected, and GDF1 was expressed at extremely low levels. These findings suggest that several members of the TGF-beta superfamily are actively involved in fracture healing and although they are closely related both structurally and functionally, each has a distinct temporal expression pattern and potentially unique role in fracture healing.
                Bookmark

                Author and article information

                Journal
                Exp Ther Med
                Exp Ther Med
                ETM
                Experimental and Therapeutic Medicine
                D.A. Spandidos
                1792-0981
                1792-1015
                November 2016
                29 September 2016
                29 September 2016
                : 12
                : 5
                : 3261-3267
                Affiliations
                [1 ]Young Scientist and Cathedras Department, National Council of Science and Technology (CONACYT), Mexico City 03940, Mexico
                [2 ]Molecular Biology and Genomics Department, University Center for Health Sciences, University of Guadalajara, Guadalajara, Jalisco 44340, Mexico
                [3 ]Surgery Department, Health Science University Center, Autonomous University of Aguascalientes, Aguascalientes, Aguascalientes 20131, Mexico
                [4 ]Health Sciences Department, Los Altos University Center at Tepatitlan, University of Guadalajara, Guadalajara, Jalisco 47620, Mexico
                [5 ]Institute of Molecular Biology in Medicine and Gene Therapy, University Center for Health Sciences, University of Guadalajara, Guadalajara, Jalisco 44340, Mexico
                [6 ]Cancer Institute of Jalisco, Guadalajara, Jalisco 44280, Mexico
                [7 ]Technical and Industrial Teaching Center (CETI) Colomos, Guadalajara, Jalisco 44638, Mexico
                [8 ]Chronic and Degenerative Disease Institute, University Center for Health Sciences, University of Guadalajara, Guadalajara, Jalisco 44340, Mexico
                [9 ]Methodological and Instrumental Disciplines Department, University Center for Health Sciences, University of Guadalajara, Guadalajara, Jalisco 44340, Mexico
                Author notes
                Correspondence to: Dr Sergio Sanchez-Enriquez, Molecular Biology and Genomics Department, University Center for Health Sciences, University of Guadalajara, Sierra Mojada 950, Guadalajara, Jalisco 44340, Mexico, E-mail: serlucis@ 123456hotmail.com
                Article
                ETM-0-0-3758
                10.3892/etm.2016.3758
                5103776
                34ebb54f-8c38-4295-8519-60bd00443939
                Copyright: © Villafan-Bernal et al.

                This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

                History
                : 11 January 2016
                : 26 July 2016
                Categories
                Articles

                Medicine
                open fracture,animal model,molecular characteristics,gene expression,bone proteins,osteoporosis,bone,osteocalcin,bone morphogenetic proteins

                Comments

                Comment on this article